Background Clinical benefit of percutaneous coronary intervention (PCI) in chronic coronary syndromes (CCS) remains ...

Researchers at University College London have identified a specific mechanism by which GLP-1 receptor agonists, the drug ...

NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB; Nasdaq:MESO), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has received a ...

A growing body of research links several widespread viral infections to sharp, short-term spikes in heart attack and stroke ...

A genome-wide association study links genetic variants to reduced coronary flow reserve, implicating the nuclear factor kappa B pathway in coronary microvascular disease.

Over the last 33 years, acting on modifiable risk factors has helped to prevent deaths caused by ischemic heart disease, new ...

A new study found that chronic wasting disease can sometimes spread silently, with infectious prions present even in animals that show no symptoms. While there is no confirmed human risk, researchers ...

Managing risk factors is the key to further progress in reducing deaths from coronary artery disease, a new study finds.

VahatiCor CEO Harry Rowland explains how the nitinol A-Flux reducer implant is designed to treat coronary microvascular ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. The global burden, secular ...

Should all adults with diabetes, including those who are asymptomatic, be screened for peripheral vascular disease (PAD)? According to Shihchen Kuo, RPh, PhD, associate research scientist of internal ...